Lacrimation, conjunctival injection, nasal congestion, sneezing ... posterior communicating, posterior cerebral, and basilar artery) or tumours, pupillary involvement is frequent, whereas pupillary ...

Pembrolizumab is under development for the treatment of newly diagnosed classical Hodgkin lymphoma, squamous cell carcinoma of paranasal sinus and nasal cavity cancer ... classical Hodgkin lymphoma, ...

Basal cell carcinomas (BCCs) are keratinocyte tumours that resemble the basal layer of the epidermis, and are the most commonly diagnosed human cancer among persons of European ancestry.

Migraine with brainstem aura or MBA (formerly known as basilar migraines) are headaches that start in the lower part of the brain, called the brainstem. They cause symptoms such as dizziness ...

Nasal irrigation can be a useful addition to the management of chronic upper respiratory conditions, including nasal congestion and chronic sinusitis Saline nasal irrigation is a therapy you can ...

Nasal irrigation can be a useful addition to the management of chronic upper respiratory conditions, including nasal ...

Basal cell carcinoma (BCC) is an epithelial tumour of the skin. It seldom metastasizes, but has the potential for local invasion and destruction. It usually occurs as one or several small pearly ...

Spokesman Mahmoud Basal told the BBC that they hoped to recover the dead within 100 days, but were likely to be delayed by a deficit of bulldozers and other essential equipment. New images from ...

The Food and Drug Administration (FDA) approved Johnson & Johnson's ketamine-derived nasal spray to help millions of U.S. patients suffering from severe depression. Spravato, approved as a ...

The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to respond to at least two oral antidepressants. However, it had to be used in ...

This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a standalone therapy for cases of depression that haven’t responded to other ...

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD ...